Leadership

C. Eric Elmquist, Ph. D.

Founder and Chief Executive Officer. Dr. Elmquist is the founder of Compliant Therapeutics and has served as President of CEO since the company’s inception. He received his Doctorate of Chemistry from Vanderbilt University and was a Postdoctoral Fellow at Massachusetts Institute of Technology, where he researched cancer related to chronic inflammation in the Department of Biological Engineering. Most recently, Dr. Elmquist served for two years at BioMimetic Therapeutics in Research & Development, where he facilitated the transition of product assays from contract organizations to on-site facilities and aided in the submission process for product approval to the FDA and EMEA.

Michael J. Moore, PhD

Scientific Advisor. Michael was born in Kimball, NE and attended the University of Nebraska in Lincoln. He received his B.S. in Biological Systems Engineering shortly after marrying his wife Lisa. They then moved to Rochester, MN, where Michael attended the Mayo Clinic College of Medicine. He pursued PhD research in the development of a biodegradable spinal cord implant under the direction of Prof. Michael Yaszemski and Prof. Anthony Windebank, and completed his PhD in 2005. Dr. Moore then went to the Massachusetts Institute of Technology where he conducted postdoctoral research in drug delivery for retinal neuroprotection under the direction of Prof. Robert Langer at MIT and Dr. Michael J. Young of the Schepens Eye Research Institute at Harvard Medical School. Dr. Moore joined the Tulane Biomedical Engineering faculty as an Assistant Professor in 2007. He and his wife Lisa and their three adorable daughters live in the Broadmoor neighborhood in New Orleans.